0001209191-22-017345.txt : 20220308
0001209191-22-017345.hdr.sgml : 20220308
20220308200130
ACCESSION NUMBER: 0001209191-22-017345
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220304
FILED AS OF DATE: 20220308
DATE AS OF CHANGE: 20220308
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ciambrone William
CENTRAL INDEX KEY: 0001794135
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14895
FILM NUMBER: 22723501
MAIL ADDRESS:
STREET 1: 215 FIRST ST
STREET 2: SUIT 415
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sarepta Therapeutics, Inc.
CENTRAL INDEX KEY: 0000873303
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 930797222
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 415
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-274-4000
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 415
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Sarepta Therapuetics, Inc.
DATE OF NAME CHANGE: 20120712
FORMER COMPANY:
FORMER CONFORMED NAME: AVI BIOPHARMA INC
DATE OF NAME CHANGE: 19980930
FORMER COMPANY:
FORMER CONFORMED NAME: ANTIVIRALS INC
DATE OF NAME CHANGE: 19970123
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-03-04
0
0000873303
Sarepta Therapeutics, Inc.
SRPT
0001794135
Ciambrone William
215 FIRST STREET, SUITE 415
CAMBRIDGE
MA
02142
0
1
0
0
EVP
Common Stock
2022-03-04
4
F
0
1160
79.20
D
14099
D
Common Stock
2022-03-07
4
A
0
8000
0.00
A
22099
D
Stock Option (right to buy)
80.42
2022-03-07
4
A
0
48000
0.00
A
2023-03-07
2032-03-07
Common Stock
48000
48000
D
Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 3, 2021.
The amount of securities directly owned by the reporting person includes the following shares of common stock purchased under the Company's Amended and Restated 2013 Employee Stock Purchase Plan: 77 shares on February 28, 2022, 75 shares on August 31, 2021, 62 shares on February 28, 2021 and 45 shares on August 31, 2020.
The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. 25% of the shares of common stock underlying each RSU will vest on the first anniversary of the grant date, and additional 25% will vest on each anniversary of the Grant Date thereafter, such that the RSUs will be fully vested on the fourth anniversary of the grant date.
Represents the date upon which the first 25% of the option granted vests. 1/48th of the total granted option vests and become exercisable on each monthly anniversary thereafter.
/s/ Ryan Brown, as Attorney-in-Fact for William Ciambrone
2022-03-08